Targeted Sequencing Market Size, Share & Trends Analysis Report By Product Type (Instruments, Kits/Panels And Assays, Services), Target Enrichment Method (Hybridization Capture, Amplicon Sequencing), Type Of Target Capture (Targeted DNA Sequencing, Targeted RNA Sequencing), Application, And End-User, By Region, And Segment Forecasts, 2025-2034

Report Id: 1658 Pages: 180 Last Updated: 04 July 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Targeted Sequencing Market-

Targeted Sequencing Market By Product Type-

  • Instruments
  • Kits/Panels and Assays
  • Services
  • Other Product Types 

https://www.insightaceanalytic.com/images_data/109505848.JPG

Targeted Sequencing Market By Target Enrichment Method-

  • Hybridization Capture
  • Amplicon Sequencing
  • Other Target Enrichment Methods

Targeted Sequencing Market By Type of Target Capture -

  • Targeted DNA Sequencing
    • Targeted Methyl Sequencing
  • Targeted RNA Sequencing
    • Targeted Metagenomic Sequencing
  • Other Types of Target Capture

Targeted Sequencing Market By Application-

  • Oncology
    • Solid Tumor
    • Liquid Biopsy
    • Minimal Residual Disease Testing
    • Circulating Tumor Cell (CTC) Analysis
  • Infectious Diseases
  • Cardiovascular Diseases
  • Reproductive Health
    • Carrier Screening
    • Non-Invasive Prenatal Testing
    • Preimplantation Genetic Diagnosis (PGD)
    • Newborn Screening
  • Rare Diseases
  • Neurological Disorders
  • Hereditary Diseases
  • Other Applications

Targeted Sequencing Market By End-User-

  • Diagnostic and Clinical Laboratories
  • Academic and Research Institutions
  • Pharmaceutical and Biotech Companies
  • Other End Users

Targeted Sequencing Market By Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Targeted Sequencing Market Snapshot

Chapter 4. Global Targeted Sequencing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:

5.2.1. Instruments
5.2.2. Kits/Panels and Assays
5.2.3. Services
5.2.4. Other Product Types

Chapter 6. Market Segmentation 2: by Target Enrichment Method Estimates & Trend Analysis
6.1. by Target Enrichment Method & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Target Enrichment Method:

6.2.1. Hybridization Capture
6.2.2. Amplicon Sequencing
6.2.3. Other Target Enrichment Methods

Chapter 7. Market Segmentation 3: by Type of Target Capture Estimates & Trend Analysis
7.1. by Type of Target Capture & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Target Capture:

7.2.1. Targeted DNA Sequencing

7.2.1.1. Targeted Methyl Sequencing

7.2.2. Targeted RNA Sequencing

7.2.2.1. Targeted Metagenomic Sequencing

7.2.3. Other Types of Target Capture

Chapter 8. Market Segmentation 4: by Application Estimates & Trend Analysis
8.1. by Application & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:

8.2.1. Oncology

8.2.1.1. Solid Tumor
8.2.1.2. Liquid Biopsy
8.2.1.3. Minimal Residual Disease Testing
8.2.1.4. Circulating Tumor Cell (CTC) Analysis

8.2.2. Infectious Diseases
8.2.3. Cardiovascular Diseases
8.2.4. Reproductive Health

8.2.4.1. Carrier Screening
8.2.4.2. Non-Invasive Prenatal Testing
8.2.4.3. Preimplantation Genetic Diagnosis (PGD)
8.2.4.4. Newborn Screening

8.2.5. Rare Diseases
8.2.6. Neurological Disorders
8.2.7. Hereditary Diseases
8.2.8. Other Applications

Chapter 9. Market Segmentation 5: by End-User Estimates & Trend Analysis
9.1. by End-User & Market Share, 2024 & 2034
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-User:

9.2.1. Diagnostic and Clinical Laboratories
9.2.2. Academic and Research Institutions
9.2.3. Pharmaceutical and Biotech Companies
9.2.4. Other End Users

Chapter 10. Targeted Sequencing Market Segmentation 6: Regional Estimates & Trend Analysis

10.1. North America

10.1.1. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.1.2. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.1.3. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.1.4. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.1.5. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.1.6. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

10.2. Europe

10.2.1. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.2.2. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.2.3. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.2.4. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.2.5. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.2.6. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

10.3. Asia Pacific

10.3.1. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.3.2. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.3.3. Asia-Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.3.4. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.3.5. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.3.6. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

10.4. Latin America

10.4.1. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.4.2. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.4.3. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.4.4. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.4.5. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.4.6. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

10.5. Middle East & Africa

10.5.1. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.5.2. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.5.3. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.5.4. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.5.5. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.5.6. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

Chapter 11. Competitive Landscape

11.1. Major Mergers and Acquisitions/Strategic Alliances

11.2. Company Profiles


11.2.1. Agilent Technologies, Inc.
11.2.2. Azenta US, Inc. (GENEWIZ)
11.2.3. BGI Group (MGI Tech Co., Ltd.)
11.2.4. CD Genomics
11.2.5. Daicel Corporation (Daicel Arbor Biosciences)
11.2.6. Danaher. (Integrated DNA Technologies, Inc.)
11.2.7. F. Hoffmann-La Roche Ltd
11.2.8. Illumina, Inc.
11.2.9. LGC Limited (LGC Biosearch Technologies)
11.2.10. PacBio.
11.2.11. PerkinElmer Inc.
11.2.12. Psomagen
11.2.13. QIAGEN N.V.
11.2.14. Takara Bio Inc.
11.2.15. Tecan Trading AG
11.2.16. Thermo Fisher Scientific Inc.
11.2.17. Twist Bioscience
11.2.18. Other Prominent Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
1803
Security Code field cannot be blank!

Frequently Asked Questions

Targeted Sequencing Market Size is valued at USD 3.9 Bn in 2024 and is predicted to reach USD 14.7 Bn by the year 2034

Targeted Sequencing Market expected to grow at a 14.4% CAGR during the forecast period for 2025-2034

Agilent Technologies, Inc., Azenta US, Inc. (GENEWIZ), BGI Group (MGI Tech Co., Ltd.), CD Genomics, Daicel Corporation (Daicel Arbor Biosciences)

Product Type, Target Enrichment Method, Type Of Target Capture, Application, and End-User are the key segments of the Targeted Sequencing Market.

North America region is leading the Targeted Sequencing Market

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying